Firmendatenbank

Category: Biotech Therapeutics & Diagnostics

Keywords: Drug Development, Small Molecules, Oncology, Rare Disease, Orphan Drug

4SC AG

4SC AG

4SC is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical need.

4SC's pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: resminostat.

4SC had 46 employees as of 31 December 2021 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C4).

Fraunhoferstraße 22
Deutschland-82152 Martinsried

Telefon: +49 (0) 89 700763-0
Fax: +49 (0) 89 700763-29
http://www.4sc.com
public@remove-this.4sc.com

Firma eintragen

Zum Login


Dr. Andreas Berghammer
Dr. Andreas Berghammer

Community Service Lead